about
Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trialCommunity risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trialThe easiest children to reach are most likely to be infected with ocular Chlamydia trachomatis in trachoma endemic areas of NigerReduction and return of infectious trachoma in severely affected communities in Ethiopia.Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distributionClinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachomaDoes mass azithromycin distribution impact child growth and nutrition in Niger? A cluster-randomized trial.Childhood mortality in a cohort treated with mass azithromycin for trachoma.Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial.Adverse events after mass azithromycin treatments for trachoma in EthiopiaLatrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia.How reliable are tests for trachoma?--a latent class approach.Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.A cluster-randomized controlled trial evaluating the effects of mass azithromycin treatment on growth and nutrition in NigerInter-Rater Agreement between Trachoma Graders: Comparison of Grades Given in Field Conditions versus Grades from Photographic ReviewLack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachomaA Cluster-Randomized Trial to Assess the Efficacy of Targeting Trachoma Treatment to Children.Estimating community prevalence of ocular Chlamydia trachomatis infection using pooled polymerase chain reaction testing.Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.Chlamydia on children and flies after mass antibiotic treatment for trachoma.Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.Mass Azithromycin and Malaria Parasitemia in Niger: Results from a Community-Randomized Trial.Trachomatous Scar Ranking: A Novel Outcome for Trachoma Studies.Metagenomic DNA Sequencing for the Diagnosis of Intraocular Infections.Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial.The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma.Mass antibiotic treatment and community protection in trachoma control programs.Complete elimination is a difficult goal for trachoma programs in severely affected communities.Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of The PRET Cluster-Randomized Trial in Niger.Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized TrialSafety of azithromycin in infants under six months of age in Niger: A community randomized trial
P50
Q28476520-71FC3AF5-C75D-4B60-87D7-7C18B6954CD9Q28482497-59F26387-37C5-4F88-A48A-33B089332186Q28484940-B40376E3-BFA7-4A34-AD8B-2B6109D004D9Q33405255-0B4F84F8-C72C-4970-8015-EBAA3C659EC2Q33496749-251C27D3-DC43-476B-A3C7-31D28B152F52Q33693683-CA118ECF-E470-4962-9649-6BC19CDAB95EQ34165923-8547A6BB-AC7C-4D53-BF79-3E3E709805B0Q35019794-85D16643-019A-47A8-9B33-73D3C2CECEA9Q35116687-6D61091B-F16F-477D-B929-5209E3E7B03BQ35131411-F4E348E1-3512-4686-AB31-BCCEE2C5E574Q35186850-4D6028FA-DB42-4EF6-9B74-8AD841F633F8Q35221151-B91BDF45-2A0D-40F0-8940-B6BB1D205979Q35632891-0664212B-BB1E-409C-BC5B-383644D19D22Q35763113-B0CB6704-AFA2-4D35-956B-9784856FC3C5Q36522988-3CDB14E9-7F66-40A6-98CA-1255A86B953DQ36715056-94328797-08AD-46E9-9B08-E2D2750E8492Q37347419-BE84622C-9623-4C18-8FE7-A3F5ED396546Q37835247-058A5127-B973-443C-9F21-76805A7773DAQ37844746-89E2470E-7B53-46C2-96AF-60B017701A24Q37849621-820B1EC7-21D2-4B72-BCB7-7F8C743B1481Q37854318-E6928142-49AA-46AF-8969-DE93AEBA72C7Q37854366-F7030835-03E6-4D1C-B17D-5CEB1F6E8944Q37855263-BE9EB157-9934-4C0D-86FB-556CD6DCC456Q37856867-177D3A9A-B09B-4226-9FD4-A90465B4728AQ37858025-A02EFDEB-6E28-43D4-AB8F-397AC5753A8EQ37860520-045C2783-AD3B-4F17-AE57-EB01884E1527Q37862751-F71C813E-18A0-44CE-8456-655D3A74D413Q37866646-3C459736-A7F9-4603-A316-FA86799A812BQ39313853-238F0051-9DB8-49C5-AA7C-B89F82706344Q40118550-DAA43D7D-C0EE-4B3A-BFA4-D32AD04E5CD6Q40205495-3BC22773-1514-411D-B613-E52892595768Q40246188-B7F5F5E2-289E-4405-988B-C0F70B7B4C74Q42962773-A40F2B10-C4A5-4887-9F3A-6ECC4FA29B1FQ45115453-49816D15-9365-4BF0-93EA-19C1CB3829A8Q46809056-E70A494C-D7D3-4F63-830D-55D100C6C39EQ53276003-14429EC1-7531-43FF-9974-79BD4BB69657Q56941131-29529AA3-D375-4776-847F-809E713D7A02Q59810763-6D775B41-BCC5-4627-B149-86E174655CFF
P50
name
Zhaoxia Zhou
@en
type
label
Zhaoxia Zhou
@en
prefLabel
Zhaoxia Zhou
@en